MD970243A - 9-O-Derivati ai oximei eritromicinei A cu proprietati antibiotice - Google Patents

9-O-Derivati ai oximei eritromicinei A cu proprietati antibiotice

Info

Publication number
MD970243A
MD970243A MD97-0243A MD970243A MD970243A MD 970243 A MD970243 A MD 970243A MD 970243 A MD970243 A MD 970243A MD 970243 A MD970243 A MD 970243A
Authority
MD
Moldova
Prior art keywords
erythromycin
oximes
derivatives
antibiotic properties
possessing antibiotic
Prior art date
Application number
MD97-0243A
Other languages
English (en)
Other versions
MD1788F2 (ro
MD1788G2 (ro
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of MD970243A publication Critical patent/MD970243A/ro
Publication of MD1788F2 publication Critical patent/MD1788F2/ro
Publication of MD1788G2 publication Critical patent/MD1788G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MD97-0243A 1994-12-13 1995-12-07 Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase MD1788G2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (3)

Publication Number Publication Date
MD970243A true MD970243A (ro) 1999-05-31
MD1788F2 MD1788F2 (ro) 2001-11-30
MD1788G2 MD1788G2 (ro) 2002-05-31

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0243A MD1788G2 (ro) 1994-12-13 1995-12-07 Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase

Country Status (35)

Country Link
US (1) US5847092A (ro)
EP (1) EP0797579B1 (ro)
JP (1) JPH10510520A (ro)
KR (1) KR100367559B1 (ro)
CN (1) CN1046535C (ro)
AP (1) AP739A (ro)
AT (1) ATE190620T1 (ro)
AU (1) AU690791B2 (ro)
BG (1) BG63261B1 (ro)
BR (1) BR9510015A (ro)
CA (1) CA2207029A1 (ro)
CZ (1) CZ289943B6 (ro)
DE (1) DE69515694T2 (ro)
DK (1) DK0797579T3 (ro)
EE (1) EE03401B1 (ro)
ES (1) ES2144154T3 (ro)
FI (1) FI972493A0 (ro)
GE (1) GEP20012391B (ro)
GR (1) GR3033622T3 (ro)
HU (1) HU220631B1 (ro)
IT (1) IT1276901B1 (ro)
LT (1) LT4276B (ro)
LV (1) LV11898B (ro)
MD (1) MD1788G2 (ro)
NO (1) NO309816B1 (ro)
NZ (1) NZ297446A (ro)
OA (1) OA10491A (ro)
PL (1) PL182053B1 (ro)
PT (1) PT797579E (ro)
RO (1) RO116282B1 (ro)
RU (1) RU2152951C1 (ro)
SI (1) SI9520124A (ro)
TJ (1) TJ306B (ro)
UA (1) UA48958C2 (ro)
WO (1) WO1996018633A1 (ro)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
RU2186389C1 (ru) * 2001-01-09 2002-07-27 Государственное федеральное учреждение науки Уральский научно-исследовательский институт травматологии и ортопедии Способ культивирования h. influenzae из носоглоточной слизи (варианты)
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
RU2207120C1 (ru) * 2001-12-29 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство брилид антибиотического действия
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
RU2240112C1 (ru) * 2003-06-09 2004-11-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
KR880009960A (ko) 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives

Also Published As

Publication number Publication date
FI972493L (fi) 1997-06-12
ES2144154T3 (es) 2000-06-01
RO116282B1 (ro) 2000-12-29
AU690791B2 (en) 1998-04-30
IT1276901B1 (it) 1997-11-03
HUT77126A (hu) 1998-03-02
JPH10510520A (ja) 1998-10-13
DE69515694D1 (de) 2000-04-20
ITMI942496A0 (it) 1994-12-13
RU2152951C1 (ru) 2000-07-20
SI9520124A (sl) 1998-04-30
TJ306B (en) 2001-08-06
UA48958C2 (uk) 2002-09-16
BR9510015A (pt) 1997-10-28
US5847092A (en) 1998-12-08
CZ289943B6 (cs) 2002-04-17
LV11898B (en) 1998-03-20
AP739A (en) 1999-03-24
AU4260396A (en) 1996-07-03
KR100367559B1 (ko) 2003-04-21
PL320688A1 (en) 1997-10-27
PL182053B1 (pl) 2001-10-31
NZ297446A (en) 1999-06-29
AP9700989A0 (en) 1997-07-31
MD1788F2 (ro) 2001-11-30
MD1788G2 (ro) 2002-05-31
NO309816B1 (no) 2001-04-02
MX9704253A (es) 1997-09-30
PT797579E (pt) 2000-08-31
OA10491A (en) 2002-04-10
NO972702D0 (no) 1997-06-12
CN1046535C (zh) 1999-11-17
BG101570A (bg) 1998-02-27
EP0797579B1 (en) 2000-03-15
LV11898A (lv) 1997-12-20
EP0797579A1 (en) 1997-10-01
GR3033622T3 (en) 2000-10-31
NO972702L (no) 1997-08-13
ATE190620T1 (de) 2000-04-15
DK0797579T3 (da) 2000-06-05
CA2207029A1 (en) 1996-06-20
CZ178697A3 (en) 1997-12-17
ITMI942496A1 (it) 1996-06-13
FI972493A7 (fi) 1997-06-12
FI972493A0 (fi) 1997-06-12
LT4276B (lt) 1998-01-26
EE03401B1 (et) 2001-04-16
EE9700124A (et) 1997-12-15
LT97116A (en) 1997-10-27
DE69515694T2 (de) 2000-10-26
GEP20012391B (en) 2001-03-25
HU220631B1 (hu) 2002-03-28
CN1169727A (zh) 1998-01-07
BG63261B1 (bg) 2001-07-31
WO1996018633A1 (en) 1996-06-20

Similar Documents

Publication Publication Date Title
MD970243A (ro) 9-O-Derivati ai oximei eritromicinei A cu proprietati antibiotice
NZ336073A (en) Crystal form 0 of clarithromycin as treatment for gram-positive bacteria, some gram-negative bacteria, mycoplasma and chlamidia
DE69127457D1 (en) 6-0-methylerythromycin a-derivat
IE832652L (en) Derivatives of epimeric azahomoerythromycin.
TR199901874T2 (xx) 3'-n-oksit,3'-n-dimetilamin, 9-oksim eritromisin A t�revleri.
PL307137A1 (en) Derivatives of 16-member cyclic antibiotic macrolydes
TR200200434T2 (tr) Yeni makrolit antibiyotikler.
FI943358A0 (fi) 16-rengasatomisten makrolidiantibioottien amidijohdannaisia
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
KR100360568B1 (en) 16-membered ring macrolide derivative and method for manufacturing the same
PL324884A1 (en) Application of prostane derivatives and their compositions with antibiotics in treating bacterial infections
ES8207218A1 (es) Un procedimiento para la preparacion de un antibiotico macrolida.
CA2234164A1 (en) Novel orthosomycins from micromonospora carbonacea
GB8811056D0 (en) Antibiotic compounds
EP0416327A3 (en) Chemical derivatives of antibiotics ll-e19020 alpha and beta
AU562464B2 (en) Macrolide ptl-448-a,b,c and d
IE811707L (en) Macrolide antibiotics
AU4835997A (en) Novel antibiotic, Feglymycin, processes for its preparation and its use
CA2471102A1 (en) Crystal form ii of clarithromycin
MX9605773A (es) Compuestos de cefalosporina y procesos para la preparacion de los mismos.

Legal Events

Date Code Title Description
PD99 Pending application
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees